Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Important Roles of Oligo-And Polysaccharides Against Sars-Cov-2: Recent Advances Publisher



Iravani S1 ; Varma RS2
Authors

Source: Applied Sciences (Switzerland) Published:2021


Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-initiated outbreak of COVID-19 has spread rapidly around the world, posing a huge threat to public health. Natural oligo-and polysaccharides with low toxicity, good sustainability, high biocompatibility, respectable safety, immune regulation, and antiviral activity can be employed as promising candidates for the prevention and inhibition of viral infections, especially COVID-19. Glycosaminoglycans, marine polysaccharides, terrestrial plant polysaccharides, and some others have exhibited potential antiviral activity against pathogenic viruses, in the format of polysaccharide-centered vaccine adjuvants, nano-based structures, drug conveyance platforms, etc. In this review, significant recent advance-ments pertaining to the antiviral applications of oligo-and polysaccharides against SARS-CoV-2 are highlighted, including important challenges and future perspectives. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
Related Docs
View other Related Docs
1. Lignin, Lipid, Protein, Hyaluronic Acid, Starch, Cellulose, Gum, Pectin, Alginate and Chitosan-Based Nanomaterials for Cancer Nanotherapy: Challenges and Opportunities, International Journal of Biological Macromolecules (2021)
2. Herbal Medicines As Potential Inhibitors of Sars-Cov-2 Infection, Current Pharmaceutical Design (2022)
3. Nanomaterials Against Pathogenic Viruses: Greener and Sustainable Approaches, Inorganic and Nano-Metal Chemistry (2020)
Experts (# of related papers)
View all Related Experts
Ghazaleh Jamalipour Soufi (3)
Laleh Shariati (2)
Other Related Docs
4. Starch, Cellulose, Pectin, Gum, Alginate, Chitin and Chitosan Derived (Nano)Materials for Sustainable Water Treatment: A Review, Carbohydrate Polymers (2021)
5. A Comprehensive Review on Potentially Therapeutic Agents Against Covid-19 From Natural Sources, Current Traditional Medicine (2024)
6. The Direct and Indirect Effects of Bioactive Compounds Against Coronavirus, Food Frontiers (2022)
7. Nanobased Platforms for Diagnosis and Treatment of Covid-19: From Benchtop to Bedside, ACS Biomaterials Science and Engineering (2021)
8. The Molecular Basis of Covid-19 Pathogenesis, Conventional and Nanomedicine Therapy, International Journal of Molecular Sciences (2021)
9. Novel Drug Design for Treatment of Covid-19: A Systematic Review of Preclinical Studies, Canadian Journal of Infectious Diseases and Medical Microbiology (2022)
10. Potential Inhibitors of Sars-Cov-2: Recent Advances, Journal of Drug Targeting (2021)
11. Quantum Dots Against Sars-Cov-2: Diagnostic and Therapeutic Potentials, Journal of Chemical Technology and Biotechnology (2022)
12. Nanosponges: An Overlooked Promising Strategy to Combat Sars-Cov-2, Drug Discovery Today (2022)
13. Trimetallic Nanoparticles: Greener Synthesis and Their Applications, Nanomaterials (2020)
14. Nanomaterials and Nanotechnology for Water Treatment: Recent Advances, Inorganic and Nano-Metal Chemistry (2021)
15. Plant Viruses and Bacteriophages for Eco-Friendly Synthesis of Nanoparticles: Recent Trends and Important Challenges, Comments on Inorganic Chemistry (2022)
16. The Favorable Impacts of Silibinin Polyphenols As Adjunctive Therapy in Reducing the Complications of Covid-19: A Review of Research Evidence and Underlying Mechanisms, Biomedicine and Pharmacotherapy (2022)
17. Immune and Bioinformatics Identification of T Cell and B Cell Epitopes in the Protein Structure of Sars-Cov-2: A Systematic Review, International Immunopharmacology (2020)
18. The Effect of Various Compounds on the Covid Mechanisms, From Chemical to Molecular Aspects, Biophysical Chemistry (2022)
19. Redox Sensitive Polysaccharide Based Nanoparticles for Improved Cancer Treatment: A Comprehensive Review, Current Pharmaceutical Design (2018)
20. Nanostructures for Prevention, Diagnosis, and Treatment of Viral Respiratory Infections: From Influenza Virus to Sars-Cov-2 Variants, Journal of Nanobiotechnology (2023)